Skip to main content

Advertisement

Table 1 Demographics and baseline characteristics

From: Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial

Mean (SD) LMWF-5A (n = 144) Saline (n = 24) Historical saline (n = 223)
Female sex, % (n) 52.8 (76) 50.0 (12) 51.6 (113)
Age, years 62.7 (9.6) 64.0 (6.3) 63.1 (8.6)
BMI (lb/in2) 32.7 (6.4) 31.4 (6.3) 34.4 (7.9)
Caucasian race 77.1 (111) 66.7 (16) 88.8 (198)
Patient global assessment (PGA) 2.8 (0.8) 2.7 (0.8) 2.6 (0.8)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
 WOMAC Pain 2.5 (0.6) 2.4 (0.4) 2.3 (0.6)
 WOMAC Stiffness 2.8 (0.7) 2.8 (0.6) 2.5 (0.7)
 WOMAC Function 2.6 (0.5) 2.5 (0.5) 2.4 (0.6)